» Authors » Alexander L Vahrmeijer

Alexander L Vahrmeijer

Explore the profile of Alexander L Vahrmeijer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 243
Citations 5623
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Henrar R, Vuijk F, Burchell G, van Dieren S, de Geus-Oei L, Kazemier G, et al.
Int J Mol Sci . 2025 Mar; 26(5). PMID: 40076605
Radiolabelled fibroblast activation protein inhibitor (FAPI) tracers have the potential to overcome the limitations of 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG) and improve the diagnosis and staging of hepato-pancreato-biliary (HPB) cancers. This study aims...
2.
Singaravelu A, Mc Entee P, Boland P, Moynihan A, McCarrick C, Vahrmeijer A, et al.
Langenbecks Arch Surg . 2025 Feb; 410(1):73. PMID: 39961820
Background: Level one evidence supports indocyanine green fluorescence angiography (ICGFA) use reducing anastomotic leak rates in colorectal surgery. We surveyed surgeons exploring perceptions and factors affecting its use in daily...
3.
Tange F, Peul R, van den Hoven P, Koning S, Kruiswijk M, Faber R, et al.
Langenbecks Arch Surg . 2025 Jan; 410(1):28. PMID: 39777554
Purpose: Assessment of tissue perfusion using near-infrared fluorescence (NIR) with indocyanine green (ICG) is gaining popularity, however reliable and objective interpretation remains a challenge. Therefore, this study aimed to establish...
4.
Palard-Novello X, Henrar R, Oprea-Lager D, Cysouw M, Schober P, de Geus-Oei L, et al.
Eur J Nucl Med Mol Imaging . 2025 Jan; 52(4):1472-1480. PMID: 39743615
Purpose: The aim of this study was to validate simplified methods for quantifying [Ga]Ga-FAPI-46 uptake against full pharmacokinetic modeling. Methods: Ten patients with pancreatobiliary cancer underwent a 90-min dynamic PET/CT...
5.
Faber R, Baart V, Bordo M, March T, Valentijn A, Harmsen S, et al.
Toxicol Appl Pharmacol . 2025 Jan; 495:117222. PMID: 39742926
Introduction: Accurate staging of malignancies often requires comprehensive evaluation of lymph nodes. However, finding these lymph nodes during oncological surgery is a daunting and time-consuming task, which increases the risk...
6.
Galema H, Neijenhuis L, Lauwerends L, Dekker-Ensink N, Verhoef C, Vahrmeijer A, et al.
Mol Imaging Biol . 2024 Nov; 26(6):955-964. PMID: 39562416
Purpose: Oesophaegal cancer patients with a clinical complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) are candidates for an active surveillance strategy. Regrowth rates of 40% after initial clinical CR indicate...
7.
Houvast R, van Duijvenvoorde M, Thijse K, de Steur W, de Geus-Oei L, Crobach A, et al.
Mol Diagn Ther . 2024 Nov; 29(2):213-227. PMID: 39541080
Purpose: Tumor-targeted positron emission tomography (PET) and fluorescence-guided surgery (FGS) could address current challenges in pre- and intraoperative imaging of gastric cancer. Adequate selection of molecular imaging targets remains crucial...
8.
Fadel M, Zonoobi E, Rodriguez-Luna M, Mishima K, Ris F, Diana M, et al.
Cancers (Basel) . 2024 Oct; 16(19). PMID: 39409997
Background: The use of fluorescence agents and imaging systems is a promising adjunct in the surgical management of colorectal cancer. This systematic review and meta-analysis aimed to assess the safety...
9.
Linders D, Bijlstra O, Walker E, March T, Pool M, Valentijn A, et al.
Pharmacol Res . 2024 Oct; 209:107464. PMID: 39401538
Up to 40 % of breast cancer patients have a tumor-positive resection margin (TPRM) - defined as cancer cells at the surface of the resected specimen - after breast-conserving surgery...
10.
Tummers F, de Koning R, Bazelmans M, Jansen F, Blikkendaal M, van Vlierberghe R, et al.
Reprod Sci . 2024 Oct; 31(12):3705-3718. PMID: 39373851
Surgical intervention for endometriosis is an important treatment modality, yet incomplete resection resulting from poor visibility of affected tissue and consequently recurrence of disease remains a prevalent challenge. Intra-operative visualization...